Stewart Campbell, PhD, is the Chief Executive Officer and Director of Axial Biotherapeutics, a clinical-stage biotech company. Based in Boston, MA.
A. Stewart Campbell, PhD, is the Chief Executive Officer and Director of Axial Biotherapeutics, a clinical-stage biotech company. He was promoted to CEO in 2021 and focuses on understanding the gut-brain microbiome interaction to develop new treatments for brain disorders.
Full founder directory · Investor directory · Company funding database · Fundraising library